Vaccines
28 April 2020
Moderna Announces IND Submitted to U.S. FDA for Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus27 April 2020
CEPI Announces COVID-19 Vaccine Development Partnership With Clover Biopharmaceuticals’ Australian Subsidiary24 April 2020
Joint development between AnGes and Osaka university for DNA vaccine targeting novel Coronavirus (COVID-19)22 April 2020
Glycovax Pharma develops a vaccine against COVID-19 – A semi-synthetic vaccine in the preclinical phase18 April 2020
Sinovac Announces Commencement of Phase I Human Clinical Trial for Vaccine Candidate Against COVID-1917 April 2020
Elicio Therapeutics and National Cancer Institute Collaborate to Study ELI-002 Mutant KRAS Targeting Mechanism15 April 2020
HALIX Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine15 April 2020
Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-1910 April 2020
ERC Launches Development Program for Novel Cell-Based Therapeutic and Prophylactic SARS-CoV-2 Vaccine10 April 2020
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development8 April 2020
Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-MayNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports